Concepedia

Z. Zu

ZZ

Statistics

Publications

5

Citations

777

H-Index

5

Active since

1994

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Z. Zu is an author at The University of Texas MD Anderson Cancer Center specializing in molecular oncology, medicine, and oncology.

Publications per year

1994–1996

5

Publications

5

Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML

AB Deisseroth, Z. Zu, David F. Claxton et al. · Blood · 1994 · 484 citations · Full text

Medicine, Genetics, Hematology +17

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

Elie G. Hanania, Richard E. Giles, J. J. Kavanagh et al. · Proceedings of the National Academy of Sciences · 1996 · 152 citations · Full text

Medicine, Cell Biology, Hematology +14

Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit.

Elie G. Hanania, Siqing Fu, Igor B. Roninson et al. · PubMed · 1995 · 81 citations

Medicine, Oncology, Pharmacology +12

Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene.

Elie G. Hanania, Siqing Fu, Z. Zu et al. · PubMed · 1995 · 42 citations

Medicine, Oncology, Pharmacology +15

PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.

Siqing Fu, Ugo Consoli, Elie G. Hanania et al. · PubMed · 1995 · 18 citations

Life Sciences, Molecular Biology, Oncology +15

1–5 of 5